Viz AAA vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Viz AAA
by Viz.ai
VS
Study Watch with Irregular Pulse Monitor (Home)
by Verily Health

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiovascular health with distinct methodologies. Viz AAA focuses on AI-powered detection and triage of acute Abdominal Aortic Aneurysms from CT scans in a hospital setting, streamlining urgent care workflows. In contrast, the Verily Study Watch is a wearable device designed for remote, continuous physiological data collection, specifically for irregular pulse monitoring and AFib detection in clinical research and home-based patient care.

Choose Viz AAA if…

Choose Viz AAA if your healthcare facility needs to rapidly identify and prioritize suspected Abdominal Aortic Aneurysm (AAA) cases directly from CT angiography scans. This AI-powered solution is ideal for emergency departments, radiology, and vascular surgery teams seeking to accelerate diagnosis, streamline care coordination through real-time alerts, and improve communication for critical vascular conditions.

View Viz AAA →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if you are conducting clinical research or require long-term, unobtrusive remote monitoring of patients for irregular pulse and potential atrial fibrillation. This prescription-only wearable is best suited for collecting continuous physiological data in a home setting, providing valuable insights for cardiology and family medicine practices managing chronic cardiac conditions.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz AAA Study Watch with Irregular Pulse Monitor (Home)
Pricing Subscription model Unknown
Deployment Cloud-based Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA offers strong usability for healthcare professionals by integrating into existing hospital workflows, providing real-time alerts, and enabling mobile access to imaging and patient information for multidisciplinary teams. This focus on streamlining clinical decision-making and communication within the care pathway directly enhances professional user experience.

Clinical Value

Viz AAA

Both tools are FDA-cleared and address significant clinical needs. However, Viz AAA provides a more immediate and impactful clinical benefit by being the first FDA-cleared AI solution for the rapid detection and triage of suspected Abdominal Aortic Aneurysm (AAA), a time-critical and life-threatening condition, directly accelerating diagnosis and care coordination to prevent catastrophic events.

Pricing & Value

Viz AAA

While both tools lack public pricing transparency, Viz AAA offers a clearer description of its subscription model, which is based on the number of algorithms and population served. Furthermore, Viz.ai has been rated #1 in 'Return on Technology Investment' in a Black Book survey, indicating a strong perceived value by its users.

Enterprise Readiness

Viz AAA

Viz AAA demonstrates superior enterprise readiness through its broad adoption by over 1700 hospitals, explicit integration into existing hospital workflows and PACS, and high ratings for ease of implementation and compatibility in multi-vendor environments. In contrast, Verily Study Watch faces concerns regarding a pending HIPAA lawsuit alleging data breaches, which could impact enterprise trust and adoption.

Innovation

Viz AAA

Viz AAA stands out as the 'first FDA-cleared AI-powered solution' for the detection and triage of suspected AAA, demonstrating pioneering innovation in applying AI to acute imaging triage and care coordination. Its comprehensive platform approach for aortic pathologies and continuous expansion into other disease areas further solidifies its innovative leadership in transforming clinical workflows.

Support & Docs

Viz AAA

Viz AAA offers a more explicitly detailed and comprehensive support structure, including dedicated 24/7 on-call specialists, implementation experts, and a customer success team. It also provides a Knowledge Base, Help Center, and User Guides, demonstrating a robust and transparent approach to user assistance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz AAA Study Watch with Irregular Pulse Monitor (Home)
Product Name Viz AAA Study Watch with Irregular Pulse Monitor (Home)
Company Viz.ai Verily Life Sciences LLC
Primary Purpose AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. Prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring.
Key Functionality AI-powered automatic detection of suspected AAA from CTA scans; Automated triage and prioritization of cases; Real-time alerts to care teams. On-demand single-channel ECG measurement; Irregular pulse monitoring for atrial fibrillation (AFib) detection; Multiple physiological sensors.
Target Condition(s) Suspected Abdominal Aortic Aneurysm (AAA) Irregular pulse (for atrial fibrillation (AFib) detection)

Videos

Demos, reviews, and walkthroughs featuring Viz AAA and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz AAA is designed to integrate into existing hospital workflows, providing real-time alerts to care teams for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, accelerating diagnosis and care coordination in emergency, radiology, and vascular surgery. The Verily Study Watch is a prescription-only wearable for unobtrusive collection of physiological data, including ECG and irregular pulse monitoring for AFib detection, best suited for remote patient monitoring in cardiology, family medicine, and internal medicine.
Viz AAA offers integration into existing hospital workflows, including EHRs, PACS, and radiology worklist systems, allowing for the transfer of relevant contextual data like patient history for alerted cases. The Verily Study Watch utilizes cloud-based data processing with proprietary algorithms, and Verily's broader platform aims to integrate diverse data, including EHR data, for a more holistic understanding of health.
Viz AAA leverages AI-powered automatic detection from CTA scans, demonstrating high sensitivity (greater than 85%) and specificity (98.3%) for AAA detection in real-world data. The Verily Study Watch uses advanced physiological sensors and cloud-based processing with proprietary algorithms and machine learning for reliable data collection, including on-demand single-channel ECG and irregular pulse monitoring for AFib detection.
Viz AAA is designed for integration into existing hospital workflows and aims to accelerate treatment decisions and improve patient outcomes, suggesting a focus on rapid adoption and quick impact on patient care. The Verily Study Watch, as a wearable, has a minimal learning curve for patients, and its value for physicians comes from continuous, unobtrusive data collection for long-term monitoring and clinical research.
The provided information for Viz AAA highlights its AI-powered automatic detection and automated triage capabilities, implying a system where decision-making processes would benefit from audit trails, though specific features are not detailed. For the Verily Study Watch, data is collected and processed in the cloud using proprietary algorithms, and while data security is emphasized, explicit audit-trail features for data changes or algorithm decisions are not specified in the provided facts.
Viz AAA's cloud-based solution and integration into existing hospital workflows, as part of the Viz AORTIC Module, suggest it is designed for scalability across multiple hospital sites to enhance identification and care coordination. The Verily Study Watch, as a wearable device with cloud-based data processing, is inherently designed for scalable collection of rich datasets across clinical and observational studies, suitable for large patient populations and global deployment.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Viz AAA or Study Watch with Irregular Pulse Monitor (Home)

Backers

Who funded each tool's parent company.

Viz AAA

Study Watch with Irregular Pulse Monitor (Home)

AI Tool Finder
AI-powered search. Results may not be comprehensive.